Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerd Otto

Showing results (61-70 of 96) with videos related to

Pageof 10
Sort By:
Clinical Transplantation|November 1, 2013
Hepatocellular carcinoma in Child's A cirrhosis: a retrospective analysis of matched pairs following liver transplantation vs. liver resection according to the intention-to-treat principleDaniel Foltys, Tim Zimmermann, Moritz Kaths, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|July 30, 2011
The recipient CYP2D6 allele 4-associated poor metabolizer status correlates with an early fibrosis development after liver transplantationTim Zimmermann, Maria Hoppe-Lotichius, Andreas Körner, et al.
Cardiovascular and Interventional Radiology|November 7, 2014
Randomized comparison of selective internal radiotherapy (SIRT) versus drug-eluting bead transarterial chemoembolization (DEB-TACE) for the treatment of hepatocellular carcinomaMichael B Pitton, Roman Kloeckner, Christian Ruckes, et al.
Hepatobiliary Surgery and Nutrition|May 1, 2023
Microvascular invasion of hepatocellular carcinoma predicts microvascular invasion of its recurrence: potential implications for salvage liver transplantation?Stefan Heinrich, Jens Mittler, Juliane Theurer, et al.
Trials|August 7, 2014
Selective internal radiotherapy (SIRT) versus transarterial chemoembolization (TACE) for the treatment of intrahepatic cholangiocellular carcinoma (CCC): study protocol for a randomized controlled trialRoman Kloeckner, Christian Ruckes, Kai Kronfeld, et al.
International Journal of Oncology|November 27, 2010
Down-regulation of CYLD as a trigger for NF-κB activation and a mechanism of apoptotic resistance in hepatocellular carcinoma cellsToni Urbanik, Bruno Christian Köhler, Regina Johanna Boger, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|November 7, 2012
Metabolic syndrome and its association with fatty liver disease after orthotopic liver transplantationMartin F Sprinzl, Arndt Weinmann, Nikola Lohse, et al.
Acta Oncologica (Stockholm, Sweden)|July 20, 2011
Dose determination using alanine detectors in a mixed neutron and gamma field for boron neutron capture therapy of liver malignanciesTobias Schmitz, Matthias Blaickner, Markus Ziegner, et al.
BMC Cancer|April 18, 2015
Treatment and survival of non-alcoholic steatohepatitis associated hepatocellular carcinomaArndt Weinmann, Yvonne Alt, Sandra Koch, et al.
Journal of Clinical Gastroenterology|February 28, 2009
Safety and efficacy of sorafenib in patients with advanced hepatocellular carcinoma in consideration of concomitant stage of liver cirrhosisMarcus Alexander Wörns, Arndt Weinmann, Kerstin Pfingst, et al.
Pageof 10

Showing results (61-70 of 96) with videos related to

Sort By:
Pageof 10
Clinical Transplantation|November 1, 2013
Hepatocellular carcinoma in Child's A cirrhosis: a retrospective analysis of matched pairs following liver transplantation vs. liver resection according to the intention-to-treat principleDaniel Foltys, Tim Zimmermann, Moritz Kaths, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|July 30, 2011
The recipient CYP2D6 allele 4-associated poor metabolizer status correlates with an early fibrosis development after liver transplantationTim Zimmermann, Maria Hoppe-Lotichius, Andreas Körner, et al.
Cardiovascular and Interventional Radiology|November 7, 2014
Randomized comparison of selective internal radiotherapy (SIRT) versus drug-eluting bead transarterial chemoembolization (DEB-TACE) for the treatment of hepatocellular carcinomaMichael B Pitton, Roman Kloeckner, Christian Ruckes, et al.
Hepatobiliary Surgery and Nutrition|May 1, 2023
Microvascular invasion of hepatocellular carcinoma predicts microvascular invasion of its recurrence: potential implications for salvage liver transplantation?Stefan Heinrich, Jens Mittler, Juliane Theurer, et al.
Trials|August 7, 2014
Selective internal radiotherapy (SIRT) versus transarterial chemoembolization (TACE) for the treatment of intrahepatic cholangiocellular carcinoma (CCC): study protocol for a randomized controlled trialRoman Kloeckner, Christian Ruckes, Kai Kronfeld, et al.
International Journal of Oncology|November 27, 2010
Down-regulation of CYLD as a trigger for NF-κB activation and a mechanism of apoptotic resistance in hepatocellular carcinoma cellsToni Urbanik, Bruno Christian Köhler, Regina Johanna Boger, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|November 7, 2012
Metabolic syndrome and its association with fatty liver disease after orthotopic liver transplantationMartin F Sprinzl, Arndt Weinmann, Nikola Lohse, et al.
Acta Oncologica (Stockholm, Sweden)|July 20, 2011
Dose determination using alanine detectors in a mixed neutron and gamma field for boron neutron capture therapy of liver malignanciesTobias Schmitz, Matthias Blaickner, Markus Ziegner, et al.
BMC Cancer|April 18, 2015
Treatment and survival of non-alcoholic steatohepatitis associated hepatocellular carcinomaArndt Weinmann, Yvonne Alt, Sandra Koch, et al.
Journal of Clinical Gastroenterology|February 28, 2009
Safety and efficacy of sorafenib in patients with advanced hepatocellular carcinoma in consideration of concomitant stage of liver cirrhosisMarcus Alexander Wörns, Arndt Weinmann, Kerstin Pfingst, et al.
Pageof 10